Potential conflict of interest: Andri Rauch and Jacques Fellay are co-applicants for patents (currently being evaluated) on the original finding of the interleukin-28B association with spontaneous and treatment-induced hepatitis C virus clearance.
Article first published online: 22 APR 2011
Copyright © 2011 American Association for the Study of Liver Diseases
Volume 53, Issue 5, pages 1446–1454, May 2011
How to Cite
di Iulio, J., Ciuffi, A., Fitzmaurice, K., Kelleher, D., Rotger, M., Fellay, J., Martinez, R., Pulit, S., Furrer, H., Günthard, H. F., Battegay, M., Bernasconi, E., Schmid, P., Hirschel, B., Barnes, E., Klenerman, P., Telenti, A., Rauch, A. and and the Swiss HIV Cohort Study (2011), Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearance. Hepatology, 53: 1446–1454. doi: 10.1002/hep.24263
The Swiss HIV Cohort Study is supported by the Swiss National Science Foundation (grants 3345CO-100935 and 324700-112655 and Swiss HIV Cohort Study grant 543) and by the Swiss HIV Cohort Study Research Foundation. Genotyping in the Swiss HIV Cohort Study is supported by an unrestricted grant from the Novartis Research Foundation. Paul Klenerman and Karen Fitzmaurice are supported by the Wellcome Trust, the James Martin 21st Century School (Oxford, United Kingdom), and the National Institute for Health Research Biomedical Research Centre (Oxford, United Kingdom). The supporters had no role in the study design, collection, analysis, or interpretation of data.
Julia di Iulio, Amalio Telenti, and Andri Rauch designed the study, established phenotypes, contributed to statistical analyses, and wrote the article. Julia di Iulio, Margalida Rotger, and Angela Ciuffi performed the genotyping, which was supervised by Amalio Telenti. Jacques Fellay and Paul Klenerman contributed to the study design and writing. All other authors contributed to the data and sample collection at the different study centers, and all authors provided a critical review of the article.
The members of the Swiss HIV Cohort Study are M. Battegay, E. Bernasconi, J. Böni, H. C. Bucher, P. Bürgisser, A. Calmy, S. Cattacin, M. Cavassini, R. Dubs, M. Egger, L. Elzi, M. Fischer, M. Flepp, A. Fontana, P. Francioli (president of the Swiss HIV Cohort Study, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland), H. Furrer (chairman of the clinical and laboratory committee), C. Fux, M. Gorgievski, H. Günthard (chairman of the scientific board), H. Hirsch, B. Hirschel, I. Hösli, C. Kahlert, L. Kaiser, U. Karrer, C. Kind, T. Klimkait, B. Ledergerber, G. Martinetti, B. Martinez, N. Müller, D. Nadal, M. Opravil, F. Paccaud, G. Pantaleo, A. Rauch, S. Regenass, M. Rickenbach (head of the data center), C. Rudin (chairman of the mother and child substudy), P. Schmid, D. Schultze, J. Schüpbach, R. Speck, P. Taffé, A. Telenti, A. Trkola, P. Vernazza, R. Weber, and S. Yerly.
Re-use of this article is permitted in accordance with the Terms and Conditions set out at http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms
- Issue published online: 22 APR 2011
- Article first published online: 22 APR 2011
- Accepted manuscript online: 28 FEB 2011 02:49PM EST
- Manuscript Accepted: 16 FEB 2011
- Manuscript Received: 17 DEC 2010
- Unknown funding agency
Additional Supporting Information may be found in the online version of this article.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.